173 related articles for article (PubMed ID: 11907129)
21. Thymic and postthymic regulation of diabetogenic CD8 T cell development in TCR transgenic nonobese diabetic (NOD) mice.
Kanagawa O; Shimizu J; Vaupel BA
J Immunol; 2000 May; 164(10):5466-73. PubMed ID: 10799914
[TBL] [Abstract][Full Text] [Related]
22. NOD background genes influence T cell responses to GAD 65 in HLA-DQ8 transgenic mice.
Abraham RS; Wilson SB; de Souza NF; Strominger JL; Munn SR; David CS
Hum Immunol; 1999 Jul; 60(7):583-90. PubMed ID: 10426275
[TBL] [Abstract][Full Text] [Related]
23. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity.
Schmidt D; Verdaguer J; Averill N; Santamaria P
J Exp Med; 1997 Oct; 186(7):1059-75. PubMed ID: 9314555
[TBL] [Abstract][Full Text] [Related]
24. Autoimmune diabetes in HLA-DR3/DQ8 transgenic mice expressing the co-stimulatory molecule B7-1 in the beta cells of islets of Langerhans.
Rajagopalan G; Kudva YC; Chen L; Wen L; David CS
Int Immunol; 2003 Sep; 15(9):1035-44. PubMed ID: 12917255
[TBL] [Abstract][Full Text] [Related]
25. Idd9/11 genetic locus regulates diabetogenic activity of CD4 T-cells in nonobese diabetic (NOD) mice.
Chen YG; Scheuplein F; Osborne MA; Tsaih SW; Chapman HD; Serreze DV
Diabetes; 2008 Dec; 57(12):3273-80. PubMed ID: 18776136
[TBL] [Abstract][Full Text] [Related]
26. Biochemical characterization of the human diabetes-associated HLA-DQ8 allelic product: similarity to the major histocompatibility complex class II I-A(g)7 protein of non-obese diabetic mice.
Reizis B; Altmann DM; Cohen IR
Eur J Immunol; 1997 Oct; 27(10):2478-83. PubMed ID: 9368599
[TBL] [Abstract][Full Text] [Related]
27. Regulation of diabetes development by regulatory T cells in pancreatic islet antigen-specific TCR transgenic nonobese diabetic mice.
Kanagawa O; Militech A; Vaupel BA
J Immunol; 2002 Jun; 168(12):6159-64. PubMed ID: 12055228
[TBL] [Abstract][Full Text] [Related]
28. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules.
Schmidt D; Amrani A; Verdaguer J; Bou S; Santamaria P
J Immunol; 1999 Apr; 162(8):4627-36. PubMed ID: 10202002
[TBL] [Abstract][Full Text] [Related]
29. Induction of insulitis by glutamic acid decarboxylase peptide-specific and HLA-DQ8-restricted CD4(+) T cells from human DQ transgenic mice.
Wen L; Wong FS; Burkly L; Altieri M; Mamalaki C; Kioussis D; Flavell RA; Sherwin RS
J Clin Invest; 1998 Sep; 102(5):947-57. PubMed ID: 9727063
[TBL] [Abstract][Full Text] [Related]
30. CD4 T cells play major effector role and CD8 T cells initiating role in spontaneous autoimmune myocarditis of HLA-DQ8 transgenic IAb knockout nonobese diabetic mice.
Hayward SL; Bautista-Lopez N; Suzuki K; Atrazhev A; Dickie P; Elliott JF
J Immunol; 2006 Jun; 176(12):7715-25. PubMed ID: 16751419
[TBL] [Abstract][Full Text] [Related]
31. Proinsulin-specific, HLA-DQ8, and HLA-DQ8-transdimer-restricted CD4+ T cells infiltrate islets in type 1 diabetes.
Pathiraja V; Kuehlich JP; Campbell PD; Krishnamurthy B; Loudovaris T; Coates PT; Brodnicki TC; O'Connell PJ; Kedzierska K; Rodda C; Bergman P; Hill E; Purcell AW; Dudek NL; Thomas HE; Kay TW; Mannering SI
Diabetes; 2015 Jan; 64(1):172-82. PubMed ID: 25157096
[TBL] [Abstract][Full Text] [Related]
32. IL-12 administration reveals diabetogenic T cells in genetically resistant I-Ealpha-transgenic nonobese diabetic mice: resistance to autoimmune diabetes is associated with binding of Ealpha-derived peptides to the I-A(g7) molecule.
Trembleau S; Gregori S; Penna G; Gorny I; Adorini L
J Immunol; 2001 Oct; 167(7):4104-14. PubMed ID: 11564833
[TBL] [Abstract][Full Text] [Related]
33. Accelerated diabetes in rat insulin promoter-tumor necrosis factor-alpha transgenic nonobese diabetic mice lacking major histocompatibility class II molecules.
Rajagopalan G; Kudva YC; Flavell RA; David CS
Diabetes; 2003 Feb; 52(2):342-7. PubMed ID: 12540606
[TBL] [Abstract][Full Text] [Related]
34. Glutamic acid decarboxylase T lymphocyte responses associated with susceptibility or resistance to type I diabetes: analysis in disease discordant human twins, non-obese diabetic mice and HLA-DQ transgenic mice.
Boyton RJ; Lohmann T; Londei M; Kalbacher H; Halder T; Frater AJ; Douek DC; Leslie DG; Flavell RA; Altmann DM
Int Immunol; 1998 Dec; 10(12):1765-76. PubMed ID: 9885897
[TBL] [Abstract][Full Text] [Related]
35. Mouse pancreatic beta cells express MHC class II and stimulate CD4(+) T cells to proliferate.
Zhao Y; Scott NA; Quah HS; Krishnamurthy B; Bond F; Loudovaris T; Mannering SI; Kay TW; Thomas HE
Eur J Immunol; 2015 Sep; 45(9):2494-503. PubMed ID: 25959978
[TBL] [Abstract][Full Text] [Related]
36. H-2D end confers dominant protection from IL-10-mediated acceleration of autoimmune diabetes in the nonobese diabetic mouse.
La Cava A; Balasa B; Good A; van Gunst K; Jung N; Sarvetnick N
J Immunol; 2001 Jul; 167(2):1066-71. PubMed ID: 11441117
[TBL] [Abstract][Full Text] [Related]
37. Cross-priming of diabetogenic T cells dissociated from CTL-induced shedding of beta cell autoantigens.
Yamanouchi J; Verdaguer J; Han B; Amrani A; Serra P; Santamaria P
J Immunol; 2003 Dec; 171(12):6900-9. PubMed ID: 14662897
[TBL] [Abstract][Full Text] [Related]
38. Two mechanisms for the non-MHC-linked resistance to spontaneous autoimmunity.
Verdaguer J; Amrani A; Anderson B; Schmidt D; Santamaria P
J Immunol; 1999 Apr; 162(8):4614-26. PubMed ID: 10202001
[TBL] [Abstract][Full Text] [Related]
39. Analysis of the role of variation of major histocompatibility complex class II expression on nonobese diabetic (NOD) peripheral T cell response.
Ridgway WM; Ito H; Fassò M; Yu C; Fathman CG
J Exp Med; 1998 Dec; 188(12):2267-75. PubMed ID: 9858513
[TBL] [Abstract][Full Text] [Related]
40. Characterization of peripheral regulatory CD4+ T cells that prevent diabetes onset in nonobese diabetic mice.
Lepault F; Gagnerault MC
J Immunol; 2000 Jan; 164(1):240-7. PubMed ID: 10605017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
